Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_assertion type Assertion NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_head.
- NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_provenance.
- NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_assertion evidence source_evidence_literature NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_provenance.
- NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_assertion SIO_000772 18473355 NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_provenance.
- NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_assertion wasDerivedFrom befree-20150227 NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_provenance.
- NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_assertion wasGeneratedBy ECO_0000203 NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_provenance.